Leishmania parasites appear to evolve through widespread genetic exchange, reshaping assumptions about how they adapt and spread.
A parasite long thought to spread mostly by cloning itself may be far more genetically dynamic than scientists once believed.
A new international study suggests that Leishmania—a group of microscopic parasites responsible for debilitating tropical diseases—regularly swaps genetic material through hybridization. The finding challenges a long-standing view of how these parasites evolve and could reshape how researchers think about their ability to spread, adapt, and potentially develop drug resistance.
Mississippi State University biologist Matthew W. Brown contributed to the study, which was published in the Proceedings of the National Academy of Sciences. The research focused on Leishmania, a genus of protistan parasites in the trypanosomatid group that are transmitted through insect bites and occur in many parts of the world.
Diseases caused by Leishmania parasites, collectively known as leishmaniasis, can range from skin ulcers to severe infections that affect internal organs. Because the parasites circulate across diverse regions and hosts, understanding how they evolve is essential for tracking disease spread and designing better prevention and treatment strategies.
Brown, the Donald L. Hall Professor of Biology in MSU's Department of Biological Sciences, helped with the genetic analysis and the interpretation of evolutionary patterns.
"Understanding how these parasites exchange genetic material fundamentally changes how we think about their evolution and adaptability," Brown said. "This work shows these parasitic organisms readily exchange genetic material—it's actually a dominant force shaping these organisms, with real implications for disease dynamics and control strategies worldwide."
Genetic exchange drives adaptation
The study pushes back against the long-held view that Leishmania populations spread mainly through clonal, or asexual, reproduction. Instead, the researchers found that genetic exchange appears to be widespread across major human-infective species.
To investigate the scale of that exchange, the team developed a pan-genus multilocus typing method using 27 genetic markers and applied it to 254 "Old World" Leishmania isolates assigned to 11 species. These isolates came from broadly distributed populations, allowing the researchers to compare genetic patterns across species and geographic regions.
Their analysis revealed high levels of heterozygosity and allelic diversity, signs that the parasites' genomes were not simply being copied from one generation to the next. Approximately 72% of the isolates showed evidence of genetic hybridization, including both interspecific hybridization between different species and intraspecific hybridization within the same species.
The researchers also conducted whole-genome sequencing on 24 isolates, which validated the broader hybridization patterns detected through the multilocus analysis.
Those findings suggest that many Leishmania parasites have mosaic ancestry, with blocks of genetic material inherited from distinct parental lineages. In other words, their evolutionary history looks less like a simple branching tree and more like a tangled network of genetic exchange.

The new publication connects to Brown's broader research on how complex organisms arose from microbial ancestors.
Last fall, Brown also took part in another international project that led to a major discovery published in Nature. That team identified a new organism, Solarion arienae, and established both a new phylum and a previously unknown eukaryotic supergroup. The finding added new detail to scientists' understanding of the earliest stages in the evolution of complex life on Earth.
Brown was named the 2025 recipient of MSU's Ralph E. Powe Research Excellence Award in recognition of his research contributions. The award is the university's highest honor for research achievement.
Brown is a leading evolutionary biologist who has written more than 70 peer-reviewed publications, received nearly 10,000 citations, and secured about $4 million in research funding. He also recently received an $870,000 collaborative grant from the Gordon and Betty Moore Foundation to expand a widely used software suite for creating large-scale evolutionary datasets.
Reference: "Extensive heterozygosity and genetic exchange among natural populations of Leishmania species" by Eliza V. C. Alves-Ferreira, Mourad Barhoumi, Tiago R. Ferreira, Matthew W. Brown, Petr Volf, Yusr Saadi-BenAoun, Immen Khammari, Ihcen Kherachi, Akila Fathallah Mili, Zoubir Harrat, Ikram Guizani, David L. Sacks, Julius Lukeš and Michael E. Grigg, 17 April 2026, Proceedings of the National Academy of Sciences.
DOI: 10.1073/pnas.2537999123
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]
Pope Leo Urges Global Response to Congo’s Deadliest Ebola Outbreak
Pope Leo called for international action to address the Ebola outbreak in the Democratic Republic of Congo. The epidemic has claimed over 2,500 lives and is the nation's largest recorded outbreak. The Pope emphasized [...]
Is there a summer COVID-19 surge this year? Yep, it’s ramping up again
Hantavirus. Ebola. West Nile. Measles. And, of course, cyclospora — that stomach parasite making people miserable across the country. Americans have plenty to worry about this summer. But remember COVID-19? It may not be [...]
Natural Compound in Broccoli Could Help Treat a Rare, Incurable Neurological Disease
Swinburne researchers have discovered how broccoli could help treat an extremely rare and incurable disease that affects only about 200 Australians. A naturally occurring compound in broccoli is being investigated as a possible treatment [...]
Antibody recycling, FcRn and the next generation of biologics
FcRn plays a central role in regulating the half-life of IgG antibodies and albumin, making it a critical target in both antibody engineering and autoimmune disease therapy. This article explores the biology of FcRn, [...]
Ebola kills 2,300 in three months with no vaccine available for Congo’s deadliest ever outbreak
It’s Congo’s 17th outbreak, with a toll that has eclipsed that of the country’s 2018-2020 outbreak when 2,299 deaths out of 3,481 cases were recorded. The latest data shows 101 new cases and 33 [...]
Beyond an Agency: How AI, Creativity and Commercialization Are Converging Into a New Growth Model
At a moment when AI is forcing a fundamental rethink of how work gets done, the life sciences industry is grappling with a deeper question: what role should human creativity play in an increasingly [...]
New $60 Blood Test Detects Lung Cancer Without Costly DNA Sequencing
A simple blood test that detects chemical changes in DNA identified more than 90% of stage 2-4 lung cancers in an early study, without relying on costly DNA sequencing. Researchers at Tel Aviv University and collaborating [...]
Reducing drug development failures with human-relevant models and AI
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers predict which drug candidates are most likely to succeed before clinical trials. Researchers now have access [...]
Half of vaccines are binned – ‘fridge-free’ versions could change that
Vaccines that do not need to be kept cool in a fridge have been successfully trialed in patients for the first time, say UK scientists. Currently, most vaccines need to be refrigerated or frozen [...]
Mushroom Mystery: The Fungus That Makes People See Tiny Humans
A mushroom sold in markets and served in restaurants in Southwest China has an unusual warning attached to it: cook it thoroughly, or you may start seeing tiny people. For decades, people have reported [...]
Artificial intelligence used to design brand new viruses
Artificial Intelligence has been used to design brand new viruses that are fully functional and can replicate in the laboratory, say US researchers. It is the first time whole genomes have been successfully designed [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from NanoappsMedical Inc.
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]















